ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $128,815 | +21.2% | 26,076 | +54.3% | 0.16% | +51.9% |
| Q4 2022 | $106,307 | -45.8% | 16,901 | -13.5% | 0.10% | -46.7% |
| Q3 2022 | $196,000 | +9.5% | 19,539 | +24.5% | 0.20% | +18.2% |
| Q2 2022 | $179,000 | -83.0% | 15,700 | -62.4% | 0.16% | -36.3% |
| Q4 2020 | $1,055,000 | -78.0% | 41,800 | -67.1% | 0.26% | -81.8% |
| Q3 2020 | $4,797,000 | +201.1% | 127,196 | +242.0% | 1.42% | +167.3% |
| Q2 2020 | $1,593,000 | +4.3% | 37,196 | -52.6% | 0.53% | -17.0% |
| Q1 2020 | $1,527,000 | -22.1% | 78,532 | +4.1% | 0.64% | -7.1% |
| Q4 2019 | $1,959,000 | -4.7% | 75,418 | 0.0% | 0.69% | -11.9% |
| Q3 2019 | $2,055,000 | +19.4% | 75,418 | +16.6% | 0.78% | +24.1% |
| Q2 2019 | $1,721,000 | – | 64,662 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |